z-logo
open-access-imgOpen Access
Long-term efficacy of darunavir/ritonavir monotherapy in patients with HIV-1 viral suppression: week 96 results from the MONOI ANRS 136 study
Author(s) -
M.A. Valantin,
Sidonie Lambert-Niclot,
Philippe Flandre,
Laurence MorandJoubert,
André Cabie,
J.L. Meynard,
Diane Ponscarme,
F. Ajana,
Laurence Slama,
Angélique Curjol,
Lise Cuzin,
L Schneider,
A M Taburet,
AnneGeneviève Marcelin,
Christine Katlama,
Claudine Duvivier,
Vincent Cálvez,
Gilles Peytavin,
S. Kolta,
Dominique Costagliola,
Michèle Genin,
M.- J. Commoy,
Marianne L’Hénaff,
Arnaud Chéret,
François Raffi,
Rodolphe Garaffo,
Diane Descamps,
Geneviève Chêne
Publication year - 2011
Publication title -
journal of antimicrobial chemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.124
H-Index - 194
eISSN - 1460-2091
pISSN - 0305-7453
DOI - 10.1093/jac/dkr504
Subject(s) - darunavir , ritonavir , medicine , human immunodeficiency virus (hiv) , virology , term (time) , viral load , antiretroviral therapy , physics , quantum mechanics
Long-term results at week 96 are needed to evaluate the capacity of the darunavir/ritonavir monotherapy strategy to maintain a sustained control of the HIV-1 viral load.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom